Your browser doesn't support javascript.
loading
Evaluation of follow-up colposcopy procedures after abnormal cervical screening result across a statewide study in Mississippi.
Reaves, Sydney; Hall, Katherine C; Stewart, Mary W; Wentzensen, Nicolas; Ferrell, Christina; Risley, Carolann; Wells, Jimmie; Rives, Rhonda; Bobo, Fajada; Daniels, Jon; Farrington, Kathy; Morgan, Jody C; Clarke, Megan A.
  • Reaves S; School of Nursing, University of Mississippi Medical Center, 2500 N State St, Jackson, MS, 39216, USA. sreaves@umc.edu.
  • Hall KC; School of Nursing, University of Mississippi Medical Center, 2500 N State St, Jackson, MS, 39216, USA.
  • Stewart MW; School of Nursing, Mississippi State University, Meridian, MS, USA.
  • Wentzensen N; Division of Cancer Epidemiology & Genetics, Clinical Genetics Branch, National Cancer Institute, Rockville, MD, USA.
  • Ferrell C; School of Nursing, University of Mississippi Medical Center, 2500 N State St, Jackson, MS, 39216, USA.
  • Risley C; School of Nursing, University of Mississippi Medical Center, 2500 N State St, Jackson, MS, 39216, USA.
  • Wells J; Cancer Research Institute, University of Mississippi Medical Center, Jackson, MS, USA.
  • Rives R; Department of Cell and Molecular Biology, University of Mississippi Medical Center, Jackson, MS, USA.
  • Bobo F; School of Nursing, University of Mississippi Medical Center, 2500 N State St, Jackson, MS, 39216, USA.
  • Daniels J; Department of Pathology, Mississippi Baptist Medical Center, Jackson, MS, USA.
  • Farrington K; Department of Pathology, University of Mississippi Medical Center, Jackson, MS, USA.
  • Morgan JC; Mississippi State Department of Health, Jackson, MS, USA.
  • Clarke MA; Mississippi State Department of Health, Jackson, MS, USA.
Article en En | MEDLINE | ID: mdl-39152278
ABSTRACT

PURPOSE:

Cervical screening is used to detect and treat precancers to prevent invasive cancers. However, successful prevention also requires adequate follow-up and treatment of individuals with abnormal screening results. The aim was to investigate demographics, clinical characteristics, and follow-up status for individuals needing colposcopy after an abnormal screening result.

METHODS:

The STRIDES (Studying Risk to Improve DisparitiES) cohort comprises individuals undergoing cervical cancer screening and management at a Mississippi Health Department or University of Mississippi clinic. Follow-up status, demographics, and clinical data were assessed from electronic health records and, if necessary, patient navigation on individuals identified as needing a colposcopy after an abnormal screening.

RESULTS:

Of the 1,458 individuals requiring colposcopy, 43.0% had the procedure within 4 months, 16.4% had a delayed procedure, and 39.5% had no documented colposcopy follow-up, with significant predictors of follow-up identified as age and cytology diagnosis. Individuals 30 + were more likely to have follow up with a colposcopy compared to individuals < 30 years (49% and 38.7%, respectively; p < .001). Individuals with cytology diagnoses of LSIL (52.9%), ASC-H (51.4%), and HSIL (62.3%) had higher percentages of adherence to follow-up guidelines (p < .001). In total, we found that 78% of individuals had some type of follow-up, including a repeat screening visit.

CONCLUSION:

Despite high cervical cancer screening rates among Mississippians, a substantial proportion did not have adequate next-step intervention. However, it is encouraging that highest risk individuals were more likely to have a colposcopy. Regardless, continuing to understand the underlying causes for incomplete follow-up is crucial for timely secondary targeted interventions to reduce cervical cancer burden, promote awareness, and improve health outcomes.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article